Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000201039 | SCV000255734 | pathogenic | Duchenne muscular dystrophy | 2012-09-17 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000506941 | SCV000603370 | pathogenic | not specified | 2017-02-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003317147 | SCV004021775 | pathogenic | not provided | 2023-02-28 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; Based on the understanding of this genetic alteration, it may be amenable to nonsense read-through therapy that is currently available or in clinical trial; This variant is associated with the following publications: (PMID: 25525159, 12233050) |